Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Diabetes

  Free Subscription


23.11.2026

1 Acta Ophthalmol
1 Am J Cardiol
2 Am J Kidney Dis
1 Am J Med
1 Am J Nephrol
3 Ann Intern Med
1 Atherosclerosis
1 Biochem Biophys Res Commun
3 BMC Ophthalmol
1 BMC Pediatr
2 Circ Arrhythm Electrophysiol
3 Diabet Med
10 Diabetes
17 Diabetes Care
12 Diabetes Obes Metab
4 Diabetologia
2 Invest Ophthalmol Vis Sci
3 J Clin Endocrinol Metab
1 J Clin Invest
2 J Diabetes Complications
1 J Nutr
3 JAMA
5 Kidney Int
1 Metabolism
2 Nature
1 Nutr Metab (Lond)
1 Ophthalmology
3 Pediatr Diabetes
9 PLoS One
1 Proc Natl Acad Sci U S A
1 Retina
1 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Ophthalmol

  1. STINO H, Tippow A, Widmann-Sedlnitzky P, Steiner I, et al
    Early intraretinal fluid volume dynamics after switching from aflibercept 2 mg to faricimab in diabetic macular oedema.
    Acta Ophthalmol. 2026 Nov 14. doi: 10.1111/aos.70270.
    PubMed         Abstract available


    Am J Cardiol

  2. NICOLAS J, Oliva A, Sartori S, Carrion-Isaacs E, et al
    Projected Cardiovascular Benefit of GLP-1 Receptor Agonist Therapy in Obese Patients Without Diabetes Undergoing Complex Percutaneous Coronary Intervention.
    Am J Cardiol. 2026 Nov 17:S0002-9149(26)00687.
    PubMed        


    Am J Kidney Dis

  3. TANGIISURAN B, Tye SC, Shah H, Galecki A, et al
    Effect Modification by Albuminuria on the Association Between Serum Biomarkers of Kidney Failure Risk and Major Kidney Events Among Patients With Type 2 Diabetes.
    Am J Kidney Dis. 2026 Nov 20:S0272-6386(26)01240.
    PubMed         Abstract available

  4. DE BOER IH
    Advances in Diabetes and CKD: A Breakthrough Decade With More to Come.
    Am J Kidney Dis. 2026;88:860-863.
    PubMed        


    Am J Med

  5. ALSHOHAIB S
    Creatinine-Only eGFR in the Low-eGFR-Only Phenotype of Diabetic Kidney Disease.
    Am J Med. 2026 Nov 18:S0002-9343(26)00824-7. doi: 10.1016/j.amjmed.2026.
    PubMed         Abstract available


    Am J Nephrol

  6. QIN L, Liang Y, Xuan Y, He R, et al
    Deciphering the Molecular and Cellular Landscape of Early Diabetic Nephropathy Through Single-Cell RNA Sequencing and Protein-Protein Interaction Networks.
    Am J Nephrol. 2026 Oct 16:ablag024. doi: 10.1159.
    PubMed         Abstract available


    Ann Intern Med

  7. ATRI-SCHULLER A, Montori VM
    In T2D, combined SGLT2i + GLP-1 RA vs. either alone does not reduce MACE or renal outcomes.
    Ann Intern Med. 2026;179:JC123.
    PubMed         Abstract available

  8. JAIN M, Stephens L
    Use of GLP-1 RAs before or during pregnancy was not linked to maternal pregnancy complications.
    Ann Intern Med. 2026;179:JC122.
    PubMed         Abstract available

  9. HTAY T
    In T2D inadequately controlled with metformin, orforglipron reduced HbA(1c) more than dapagliflozin at 40 wk.
    Ann Intern Med. 2026;179:JC124.
    PubMed         Abstract available


    Atherosclerosis

  10. NARUM M, Christensen JJ, Melnes T, Holven KB, et al
    High levels of large HDL particles in long-term survivors of type 1 diabetes or familial hypercholesterolemia free from coronary heart disease events.
    Atherosclerosis. 2026;424:121954.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  11. LAMICHHANE R, Shin CY, Park GE, Lim JS, et al
    Quercetin-3-O-rhamnoside improves insulin sensitivity and attenuates pancreatic islet hypertrophy in high-fat diet-fed diabetic mice.
    Biochem Biophys Res Commun. 2026;844:154890.
    PubMed         Abstract available


    BMC Ophthalmol

  12. NISAR I, Moin M, Aslam B, Awan M, et al
    Comparison of corneal higher order aberrations in diabetics versus non-diabetics after cataract surgery.
    BMC Ophthalmol. 2026;26:769.
    PubMed         Abstract available

  13. SHEN X, Sun Z, Zhou R, Li Y, et al
    Anxiety factors in patients with diabetic retinopathy undergoing panretinal photocoagulation.
    BMC Ophthalmol. 2026;26:772.
    PubMed         Abstract available

  14. SARITAS O, Akyuz M, Gokpinar EY, Tasci YY, et al
    Arterial thromboembolic events during long-term intravitreal anti-VEGF therapy: incidence, associated factors, and mortality in a retrospective cohort study.
    BMC Ophthalmol. 2026;26:761.
    PubMed         Abstract available


    BMC Pediatr

  15. GEZAE KE, Zelelow YB, Meles GG, Gebrekidan GB, et al
    Trends and patterns of low birth weight and fetal macrosomia in a tertiary hospital, Northern Ethiopia, 2012-2021: multinomial modeling approach.
    BMC Pediatr. 2026;26:1201.
    PubMed         Abstract available


    Circ Arrhythm Electrophysiol

  16. WANG L, Tan R, Sun Y, Xu G, et al
    Myocardial Hmgcs2-Driven Ketogenesis Promotes Atrial Fibrillation in Diabetes.
    Circ Arrhythm Electrophysiol. 2026 Nov 18:e014935.
    PubMed         Abstract available

  17. ASHOK V, Lim VG, Rahim SMZ, Sandhu H, et al
    Cardiac Electrophysiological Impact of Sodium Glucose Cotransporter 2 Inhibitors: A Comprehensive Review.
    Circ Arrhythm Electrophysiol. 2026;19:e015246.
    PubMed         Abstract available


    Diabet Med

  18. ABRAHAM MB, Delaney PWJ, Smith G, Dart JA, et al
    Redefining glucose thresholds for hypoglycaemia management in children and young adults with type 1 diabetes on automated insulin therapy: A cross-over clinical trial protocol.
    Diabet Med. 2026 Nov 19:e70536. doi: 10.1111/dme.70536.
    PubMed         Abstract available

  19. PIERI B, Verma A, Martine-Edith G, Koutroukas V, et al
    Impact of acute hyperglycaemia on cognitive function in people with diabetes: A systematic review.
    Diabet Med. 2026 Nov 18:e70515. doi: 10.1111/dme.70515.
    PubMed         Abstract available

  20. PIGOTT A, Broughton J, Gallimore K, Prior AL, et al
    Lived experiences of type 1 diabetes and disordered eating: Insights for prevention and early intervention in Paediatric care.
    Diabet Med. 2026 Nov 13:e70527. doi: 10.1111/dme.70527.
    PubMed         Abstract available


    Diabetes

  21. JAMES DE
    The Insulin Resistance Mosaic: Defect, Defense, or Both? A Perspective on What Insulin Resistance Means and Whether It Should be Treated.
    Diabetes. 2026;75:2166-2171.
    PubMed         Abstract available

  22. DOGAN F, El Babsiri A, Ozkan E, Ye S, et al
    Microgels Containing Protease-Resistant CXCL12 and FasL Enable Long-term Allo-Islet Function Without Systemic Immunosuppression.
    Diabetes. 2026;75:2330-2342.
    PubMed         Abstract available

  23. LIU Y, Tsuchida H, Kubota S, Kubota-Okamoto S, et al
    Olive Oil Before Oral Glucose Delays Gastric Emptying and Lowers Glycemia Through Partially Redundant Glucagon and GLP-1 Signaling in Mice.
    Diabetes. 2026;75:2205-2216.
    PubMed         Abstract available

  24. MARTIN NK, Heuer LS, Urbano IM, Cohen SL, et al
    Reversal of T1D and Rapid Reduction of beta-Cell Stress by IL-10-Dependent MDSCs Induced by TLR4-Ab.
    Diabetes. 2026;75:2358-2369.
    PubMed         Abstract available

  25. RAGOZZINO G, Fulgione E, Cantelli M, Mattera E, et al
    Comment on Stefan MASLD as Complication of Diabetes.
    Diabetes. 2026;75:e43-e44.
    PubMed        

  26. STEFAN N
    Response to Comment on Stefan MASLD as Complication of Diabetes.
    Diabetes. 2026;75:e45.
    PubMed        

  27. PAGE B
    Diabetes Spotlight: Daniela Menichella, MD, PhD: Neuropathy and Communication Between Neurons and Nonneuronal Cells.
    Diabetes. 2026;75:2119-2120.
    PubMed        

  28. CALLEBAUT A, Jones AR, Manganaro A, Velarde de la Cruz EE, et al
    Nonenzymatic Asn Deamidation of GAD65 Generates HLA-DRB1*03:01-Restricted Neoepitopes in Type 1 Diabetes.
    Diabetes. 2026 Nov 16:db260296. doi: 10.2337/db26-0296.
    PubMed         Abstract available

  29. HASEBE M, Yoshiji S
    Population-Scale, Genotype-First Characterization of Monogenic Diabetes in 374,973 Individuals Across Ancestries in the NIH All of Us Research Program.
    Diabetes. 2026 Nov 18:db260566. doi: 10.2337/db26-0566.
    PubMed         Abstract available

  30. RUI S, Li X, Xiao F, Qin Y, et al
    Endothelial GDF15 Promotes Vascular Repair and Diabetic Wound Healing via Src-AKT Signaling.
    Diabetes. 2026 Nov 20:db260431. doi: 10.2337/db26-0431.
    PubMed         Abstract available


    Diabetes Care

  31. BENHADDOU MM, van Sloten TT
    Cardiovascular Health, Genetics, and Risk of Dementia in Diabetes.
    Diabetes Care. 2026;49:2278-2279.
    PubMed        

  32. JAMES DE
    The Insulin Resistance Mosaic: Defect, Defense, or Both? A Perspective on What Insulin Resistance Means and Whether It Should be Treated.
    Diabetes Care. 2026;49:2211-2216.
    PubMed         Abstract available

  33. ALFALKI AM, Julceus EF, Bekelman TA, Frongillo EA, et al
    Food Insecurity Patterns and Risk of Poor Glycemic Control, Acute Complications of Diabetes, and Ability to Obtain Diabetes Technologies in Youth and Young Adults With Youth-Onset Type 1 Diabetes.
    Diabetes Care. 2026 Nov 18:dc261885. doi: 10.2337/dc26-1885.
    PubMed         Abstract available

  34. LIND M, Anderbro T, Hellman J, Catrina SB, et al
    The Effect of a Diabetes-Educated Psychologist on HbA1c and Diabetes Distress in Adults With Type 1 Diabetes: A Multicenter, Open-Label, Randomized Controlled Trial.
    Diabetes Care. 2026 Nov 20:dc261843. doi: 10.2337/dc26-1843.
    PubMed         Abstract available

  35. FOPPIANI A, Ciciriello F, Marelli B, Sileo F, et al
    Early-Phase C-Peptide Response as a Candidate Predictor of Cystic Fibrosis-Related Diabetes in People With Normal Glucose Tolerance: A Multicenter Retrospective Survival Analysis.
    Diabetes Care. 2026 Nov 20:dc261988. doi: 10.2337/dc26-1988.
    PubMed         Abstract available

  36. QIN J, Chen T, Qu L
    Comment on Longo et al. Blood-Based DNA Methylation Models Improve Short-term Cardiovascular Risk Stratification in Individuals With Type 2 Diabetes.
    Diabetes Care. 2026;49:e226.
    PubMed        

  37. CHEN T, Chen Y, Qu L
    Comment on Calligaro et al. 30-Year Trends in Microvascular Complications and Treatment in Adolescents With Type 1 Diabetes.
    Diabetes Care. 2026;49:e215.
    PubMed        

  38. ZHANG Y, Liu J, Wu Y
    Comment on Young et al. Precision Prescribing of SGLT2 Inhibitors in Individuals With Type 2 Diabetes for Primary Prevention of Heart Failure: Model Development and Validation Study.
    Diabetes Care. 2026;49:e220-e221.
    PubMed        

  39. BRUGGEMAN BS, Foster TP, Hiers PS, Haller MJ, et al
    BANDIT on the Run: The Race to Maintain beta-Cell Preservation in Type 1 Diabetes.
    Diabetes Care. 2026;49:2282-2284.
    PubMed        

  40. VITALE RJ, Fruik A, Kahkoska AR
    Dietary Modifications for Weight Loss in Type 1 Diabetes: Not Quite Clockwork.
    Diabetes Care. 2026;49:2280-2281.
    PubMed        

  41. WERNER EF, Lowe WL Jr, Facco FL, Grobman WA, et al
    Response to Comment on the GO MOMS Study Group. Early Pregnancy Glycemic Testing for Prediction of Gestational Diabetes Mellitus and Large-for-Gestational-Age Birth Weight.
    Diabetes Care. 2026;49:e218-e219.
    PubMed        

  42. YOUNG KG, McGovern AP, Hopkins R, Jansz TT, et al
    Response to Comment on Young et al. Precision Prescribing of SGLT2 Inhibitors in Individuals With Type 2 Diabetes for Primary Prevention of Heart Failure: Model Development and Validation Study.
    Diabetes Care. 2026;49:e222-e223.
    PubMed        

  43. CHEN T, Chen Y, Qu L
    Comment on Pyatak et al. Habituation to Elevated Glucose Levels in Type 1 Diabetes: Function and Well-being in Guideline-Based Versus Typical Glycemic Range.
    Diabetes Care. 2026;49:e224-e225.
    PubMed        

  44. SHAN R, Chen T, Qu L
    Comment on Feodoroff et al. Fracture Risk Is Increased in Type 1 Diabetes and Is the Highest in Individuals With Diabetic Kidney Disease.
    Diabetes Care. 2026;49:e227.
    PubMed        

  45. CALLIGARO LI, Chan A, Craig ME, Donaghue KC, et al
    Response to Comment on Calligaro et al. 30-Year Trends in Microvascular Complications and Treatment in Adolescents With Type 1 Diabetes.
    Diabetes Care. 2026;49:e216.
    PubMed        

  46. HANSEN KW
    Comment on Ajjan et al. Glucose-Derived Personalized HbA1c Correction (GDAC) Study to Improve Alignment Between CGM-Derived Metrics and HbA1c in Different Individuals and Racial Groups With Diabetes: Implications for Clinical Practice.
    Diabetes Care. 2026;49:e228-e229.
    PubMed        

  47. WIGGERS S, Ahmed JFA, Jensen AKS, Sorensen A, et al
    Comment on the GO MOMS Study Group. Early Pregnancy Glycemic Testing for Prediction of Gestational Diabetes Mellitus and Large-for-Gestational-Age Birth Weight.
    Diabetes Care. 2026;49:e217.
    PubMed        


    Diabetes Obes Metab

  48. ZHANG Y, Lui DT, Wong KH, Ma IK, et al
    Real-World Effectiveness of SGLT2i on Incident Kidney Outcomes in Patients With Type 2 Diabetes and Normoalbuminuria-A Territory-Wide Retrospective Study.
    Diabetes Obes Metab. 2026 Nov 19. doi: 10.1111/dom.71553.
    PubMed         Abstract available

  49. WEIGELT M, Bunk M, Stock J, Thetmeyer D, et al
    Sensitive First Line Screening for Early-Stage Type 1 Diabetes on Dried Blood Spots.
    Diabetes Obes Metab. 2026 Nov 19. doi: 10.1111/dom.71566.
    PubMed        

  50. LU Y, Tian Z, Niu J, Gao D, et al
    Early Continuous Glucose Monitoring to Lower the Risk of Gestational Diabetes Mellitus in Women With Pre-Pregnancy Obesity: Protocol for the Multicentre Randomised Controlled Trial (GLOW).
    Diabetes Obes Metab. 2026 Nov 18. doi: 10.1111/dom.71563.
    PubMed         Abstract available

  51. SUN H, Ni J, Han B, Chen J, et al
    Association of Continuous Glucose Monitoring-Based Nocturnal Glucose Patterns With Microvascular Complications in Patients With Type 2 Diabetes.
    Diabetes Obes Metab. 2026 Nov 16. doi: 10.1111/dom.71560.
    PubMed         Abstract available

  52. SCHIERBAUER J, Renfordt M, Greco F, Sanfilippo S, et al
    Comparison of Sensor Accuracy for Three Different CGM-Systems Using Either Displayed or Auto-Logged Values in Individuals With Type 1 Diabetes Mellitus.
    Diabetes Obes Metab. 2026 Nov 16. doi: 10.1111/dom.71537.
    PubMed        

  53. HONG JH, Lyu YS, Park S, Cho HC, et al
    Efficacy and Safety of Anagliptin Added to Metformin and Empagliflozin 10 mg in Korean Adults With Type 2 Diabetes: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase III Trial.
    Diabetes Obes Metab. 2026 Nov 16. doi: 10.1111/dom.71501.
    PubMed         Abstract available

  54. DE LA RAMBELJE MA, Nair V, Jongs N, Menon R, et al
    Urinary Metabolic and Hemodynamic Protein Signatures in Canagliflozin Treated Patients With Diabetic Kidney Disease: Findings From CREDENCE.
    Diabetes Obes Metab. 2026 Nov 15. doi: 10.1111/dom.71518.
    PubMed         Abstract available

  55. THIYAGARAJAH K, Shen J, Parikh M, Zinman B, et al
    Pre-Treatment Biomarkers Associated With Remission of Type 2 Diabetes in Response to Short-Term Insulin-Based Therapy.
    Diabetes Obes Metab. 2026 Nov 15. doi: 10.1111/dom.71551.
    PubMed         Abstract available

  56. ZHAO L, Zhang Z, Wang J, Wu D, et al
    Polygenic Risk for Type 2 Diabetes, Multiple Risk Factor Control and Cardiovascular and Non-Cardiovascular Mortality.
    Diabetes Obes Metab. 2026 Nov 15. doi: 10.1111/dom.71521.
    PubMed         Abstract available

  57. AMRITLAL ST, Paterson L, Hoang MT, Choudhary P, et al
    A Cost-Effectiveness Analysis of FreeStyle Libre Real-Time Continuous Glucose Monitoring System Compared With Self-Monitoring of Blood Glucose in Adults With Type 2 Diabetes on Basal Insulin Plus SGLT2 Inhibitor and/or GLP-1 Agonists in the United Kin
    Diabetes Obes Metab. 2026 Nov 15. doi: 10.1111/dom.71476.
    PubMed         Abstract available

  58. DE SANCTIS L, Delvecchio M, Di Molfetta S, Girelli A, et al
    Societal and Economic Burden of Type 1 Diabetes Across Disease Stages in Italy.
    Diabetes Obes Metab. 2026 Nov 15. doi: 10.1111/dom.71520.
    PubMed        

  59. WEISS A, Winkler C, Bonifacio E, Ziegler AG, et al
    Validation of the Progression Likelihood Score (PLS) for Stratifying Progression Rates in Early-Stage Type 1 Diabetes.
    Diabetes Obes Metab. 2026 Nov 13. doi: 10.1111/dom.71561.
    PubMed        


    Diabetologia

  60. MOON SJ, Kim JY, Cho JH, Jun JE, et al
    Smart insulin pens with integrated bolus calculator vs tracking-only connected insulin pens in adults with diabetes on multiple daily injections: a multicentre randomised controlled trial.
    Diabetologia. 2026 Nov 14. doi: 10.1007/s00125-026-06914.
    PubMed         Abstract available

  61. AL-BANAA NN, Bell GI, Cooper TT, Tian Y, et al
    Dual stimulation of Wnt and IFN-gamma pathways in human bone marrow-derived multipotent stromal cells produces an activated secretome that modulates autoimmune diabetes in NOD mice.
    Diabetologia. 2026 Nov 14. doi: 10.1007/s00125-026-06918.
    PubMed         Abstract available

  62. DUAN S, Qin N, Pi J, Huang CP, et al
    Correction: Liver-to-kidney apolipoprotein J trans-accumulation exacerbates diabetic renal injury by disrupting TFEB-mediated lipid homeostasis.
    Diabetologia. 2026 Nov 19. doi: 10.1007/s00125-026-06926.
    PubMed        

  63. FERRAT LA, Templeman EL, Sims EK
    The role of sex in explaining the heterogeneity of type 1 diabetes.
    Diabetologia. 2026 Nov 18. doi: 10.1007/s00125-026-06927.
    PubMed         Abstract available


    Invest Ophthalmol Vis Sci

  64. BATTISTA M, Lingardo S, Borrelli E, Carbonelli M, et al
    Topographic Ellipsoid Zone Reflectivity in Hereditary Optic Neuropathies.
    Invest Ophthalmol Vis Sci. 2026;67:38.
    PubMed         Abstract available

  65. ALESSIO EJ, Lee JY, Palia RS, Tate AJ, et al
    Early Retinal Vascular Dysfunction Precedes Detectable Structural Pathology in a Mouse Model of Type 1 Diabetes.
    Invest Ophthalmol Vis Sci. 2026;67:26.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  66. KUO B, Nam S, Kaur V, Jones F, et al
    Genetic and clinical factors associated with metformin plasma concentrations following an acute metformin challenge.
    J Clin Endocrinol Metab. 2026;111:3399-3408.
    PubMed         Abstract available

  67. LADD JM, Weaver MS, Henry RK
    Approach to the patient: ethics cases in pediatric endocrinology and their management.
    J Clin Endocrinol Metab. 2026;111:e2523-e2531.
    PubMed         Abstract available

  68. SELEN DJ, Pant D, Thaweethai T, James K, et al
    Physiologic subtypes of gestational glucose intolerance and risk of future maternal prediabetes or diabetes.
    J Clin Endocrinol Metab. 2026 Nov 21:dgag470. doi: 10.1210.
    PubMed         Abstract available


    J Clin Invest

  69. HUANG X, Roth BL
    Chemogenetics reveals a surprising role for GPR18 signaling in immunometabolic regulation of beta cell activity.
    J Clin Invest. 2026;136:e212477.
    PubMed         Abstract available


    J Diabetes Complications

  70. MOHAMED AA, Mesbah NM, Abdel-Hamed AR, Mtwaly K, et al
    TNF-alpha, fasting insulin, and microRNA-192 as biomarkers of disease severity and complications in pediatric type 1 diabetes mellitus.
    J Diabetes Complications. 2026;41:109436.
    PubMed         Abstract available

  71. ROSSATTO T, de Andrade Oliveira R, Manica A, Cardoso AM, et al
    Beyond weight loss: GLP-1-based therapies and the reversal of type 2 diabetes pathophysiology.
    J Diabetes Complications. 2026;41:109453.
    PubMed         Abstract available


    J Nutr

  72. NAYAR S, Madhu SV
    Beyond glycemic index: Mixed meal postprandial glycemic response as a promising approach for Personalized Nutrition in Diabetes.
    J Nutr. 2026 Nov 13:101940. doi: 10.1016/j.tjnut.2026.101940.
    PubMed         Abstract available


    JAMA

  73. FOX CK, Armstrong SC, Kelly AS
    Obesity in Children Aged 2 to 12 Years: A Review.
    JAMA. 2026;336:1757-1766.
    PubMed         Abstract available

  74. ANDERER S
    Updated Guidance Released for Type 2 Diabetes Care.
    JAMA. 2026 Nov 13. doi: 10.1001/jama.2026.20048.
    PubMed        

  75. RICHMOND S
    FDA Approves Weekly Insulin for Pediatric Type 2 Diabetes.
    JAMA. 2026 Nov 20. doi: 10.1001/jama.2026.24049.
    PubMed        


    Kidney Int

  76. MORTENSEN LA, Bistrup C, Rittig S, Hertz JM, et al
    Impact of fluconazole in vasopressin 2 receptor-related congenital arginine vasopressin resistance.
    Kidney Int. 2026;110:1594-1601.
    PubMed         Abstract available

  77. GATELY R, Qi L, Teixeira-Pinto A, Lim WH, et al
    Predicting the trajectory of nondiabetic kidney disease in patients with diabetes: are we any clearer?
    Kidney Int. 2026;110:1602.
    PubMed        

  78. CAZA TN, Walker PD
    Authors' response to "Predicting the trajectory of nondiabetic kidney disease in patients with diabetes: are we any clearer?".
    Kidney Int. 2026;110:1603.
    PubMed        

  79. EVENEPOEL P, Jorgensen HS, Hansen D
    Diabetes does not inherently imply adynamic bone in chronic kidney disease.
    Kidney Int. 2028 Jun 26:S0085-2538(26)00522-3. doi: 10.1016/j.kint.2026.
    PubMed        

  80. DUQUE EJ, Moyses RMA
    Skeletal phenotype in patients with diabetes and chronic kidney disease: the sweeter it is, the slower it goes.
    Kidney Int. 2028 Jun 26:S0085-2538(26)00521-1. doi: 10.1016/j.kint.2026.
    PubMed        


    Metabolism

  81. LI Y, Li J, Zhao C, Yang L, et al
    Corrigendum to "Hyperglycemia-reduced NAD(+) biosynthesis impairs corneal epithelial wound healing in diabetic mice" [Metabolism 114 (2021) 154402].
    Metabolism. 2026;186:156821.
    PubMed        


    Nature

  82. IMAI J
    Glucose-powered implant brings devices for treating diabetes a step closer.
    Nature. 2026;659:606-608.
    PubMed        

  83. XIU W, Wang Q, Wan L, Liang Z, et al
    A glucose-powered artificial neuroimmune axis for metabolic control.
    Nature. 2026;659:647-656.
    PubMed         Abstract available


    Nutr Metab (Lond)

  84. DAI F, Cai Y, Li H, Dai Y, et al
    High BMI drives diabetes burden and risk: evidence from global trends and multi-country cohorts.
    Nutr Metab (Lond). 2026;23:136.
    PubMed         Abstract available


    Ophthalmology

  85. VARMA R
    Beyond the Average: Diabetic Retinopathy across Hispanic and Latino Populations.
    Ophthalmology. 2026 Nov 20:S0161-6420(26)00834.
    PubMed        


    Pediatr Diabetes

  86. HUANG D, Sun P, Pan M, Li J, et al
    Burden of diabetes and related chronic kidney diseases in adolescents and young adults aged 10-24 years in China from 1990 to 2021, with projections to 2050: a secondary analysis of the Global Burden of Disease Study 2021.
    Pediatr Diabetes. 2026;2026:e013.
    PubMed         Abstract available

  87. NOISZEWSKA K, Jamiolkowska-Sztabkowska M, Zasim A, Polkowska A, et al
    Identifying children and adolescents with preclinical type 1 diabetes among first-degree relatives of type 1 diabetes patients: a Polish pilot study (pre-d1abetes study).
    Pediatr Diabetes. 2026;2026:e012.
    PubMed         Abstract available

  88. ZGHAL Y, Cremona MA, Henderson M, Rekik M, et al
    Deep learning-based blood glucose prediction in pediatric type 1 diabetes patients exercising in free-living conditions.
    Pediatr Diabetes. 2026;2026:e011.
    PubMed         Abstract available


    PLoS One

  89. ONYUTH H, Nath ND, Chavez-Lindell T, Epuwatt AO, et al
    A descriptive study of diabetes management practices among persons with diabetes in rural and urban Tororo District, Uganda.
    PLoS One. 2026;21:e0359139.
    PubMed         Abstract available

  90. IWASHITA H, Ahmad I, Masuda G, Rawal L, et al
    Scoping review of HbA1c device use in selected Asian countries: Implications for point-of-care testing in Nepal.
    PLoS One. 2026;21:e0340245.
    PubMed         Abstract available

  91. CHAIYACHATE K, Pongsamakthai M, Jamnongkan W, Phetcharaburanin J, et al
    Untargeted plasma metabolomics reveals metabolite alterations and pathway perturbations in gestational diabetes mellitus.
    PLoS One. 2026;21:e0362854.
    PubMed         Abstract available

  92. MUIR BC, Nickerson KA, Carranza C, Varre MS, et al
    Improving offloading in diabetic feet: 3D-printed custom accommodative insoles outperform standard of care.
    PLoS One. 2026;21:e0363325.
    PubMed         Abstract available

  93. GAVOR-KWASHI CEK, Ryabinina O, Badu Nyarko S, Aku Addo N, et al
    Cardiometabolic multimorbidity and associated clinical, lifestyle and genetic factors among Ghanaian patients.
    PLoS One. 2026;21:e0362848.
    PubMed         Abstract available

  94. HRIDOY RA, Dibbay SS, Adnan Palash MI, Paul A, et al
    MoViT-Eye model: A robust and explainable AI-driven approach for automated multi-class ocular disease diagnosis.
    PLoS One. 2026;21:e0360848.
    PubMed         Abstract available

  95. SOLEIM SB, Lovas K, Softeland E, Ueland GA, et al
    Trends and outcomes in diabetic ketoacidosis: A 10-year retrospective study at a Norwegian university hospital.
    PLoS One. 2026;21:e0362629.
    PubMed         Abstract available

  96. MUTISYA CM, Nduwimana M, Kajoba D, Ndeezi G, et al
    High blood pressure among children and adolescents with type 1 diabetes mellitus in Uganda: A multicenter cross-sectional study.
    PLoS One. 2026;21:e0363283.
    PubMed         Abstract available

  97. RAJ S, Shetty S, Suvarna R, Thunga G, et al
    Bioelectrical impedance analysis versus dual-energy X-ray absorptiometry for sarcopenia assessment in type 2 diabetes mellitus: A systematic review and meta-analysis.
    PLoS One. 2026;21:e0353604.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  98. NGUYEN TP, Suzuki S, Okamoto K, Ito R, et al
    ChREBP drives diabetic kidney disease, and its inhibition confers renal protection.
    Proc Natl Acad Sci U S A. 2026;123:e2537870123.
    PubMed         Abstract available


    Retina

  99. JANMOHAMED IK, Harahn H, Khan M, Sahbi S, et al
    Long-term Outcomes of Combined Phacoemulsification and Intravitreal Dexamethasone Implant in Diabetic Macular Oedema.
    Retina. 2026 Nov 20. doi: 10.1097/IAE.0000000000005062.
    PubMed         Abstract available


    Transplantation

  100. DALAL N, Bhardwaj A, Yoshida Y, Borgi J, et al
    Glucagon-like Peptide-1 Receptor Agonists Versus Dipeptidyl Peptidase-4 Inhibitors in Heart Transplant Recipients With Type 2 Diabetes Mellitus: A Propensity Score-Matched Analysis.
    Transplantation. 2026 Nov 20. doi: 10.1097/TP.0000000000005982.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum